Cerecor raised $16 million for phase II clinical study of antidepressants

Chengdu rongchuang Yiheng Biomedical Technology Co., Ltd., established in 2017, mainly focuses on the customization, R & D and sales of pharmaceutical intermediates, chemicals and impurities. Its main products include chiral acid series, chiral amine series, etc. At present, the R & D laboratory covers an area of 300 square meters. It has a group of synthetic process engineers with high attainments in organic chemistry, pharmaceutical chemistry and other disciplines. It has its own unique advantages in pilot production and optimization of chiral compounds. The company has complete scientific research and test equipment and the most modern analysis and detection instruments, which can complete the g-level custom synthesis and kg level process development experiments. We are willing to use the best products, the best service, the best reputation to become your most reliable long-term partner.